Skip to main content

Kenvue Inc.

corporate_fare Company Profile

Kenvue Inc.

KVUE·NYSE·Industrial Applications And Services·CIK 0001944048

Kenvue is a global leader in consumer health, operating at the intersection of healthcare and consumer goods. The company is the world's largest pure-play consumer health company by revenue, with $15.1 billion in Net sales in the fiscal year 2025. Kenvue combines science, consumer insights, and a digital strategy to help consumers live healthier lives. Its portfolio of brands, built on over a century of heritage, includes Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena®, Nicorette®, Tylenol®, and Zyrtec®. These brands are backed by science and recommended by healthcare professionals. Kenvue's product portfolio is divided into three segments: Self Care, Skin Health and Beauty, and Essential Health products. The company markets its products across more than 165 countries worldwide, reaching consumers in North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM). Kenvue's global scale and broad brand portfolio are supported by its capabilities and digital strategy, enabling it to respond to trends in its categories and geographic markets. The marketing organization uses precision marketing, e-commerce, and digital capabilities to develop consumer insights and enhance brand relevance. The research and development organization combines these insights with scientific expertise and engagement with healthcare professionals to drive innovative new products and solutions centered on consumer health.

Kenvue Inc. (NYSE:KVUE) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 32 items for KVUE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for KVUE spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • Kimberly-Clark Completes $40B Kenvue Takeover; KVUE to Delist
  • Kenvue Posts 3Q EPS of 22 Cents
  • Court Denies Kenvue Rehearing, Reviving 500 Tylenol Autism Suits
  • EU Clears $40B Kimberly-Clark-Kenvue Deal With Divestitures
  • Kenvue Strips Bond Covenants Ahead of Kimberly-Clark Merger Close

Financial Snapshot

Fiscal year ended December 28, 2025
Revenue
$15.12B
Net Income
$1.47B
Diluted EPS
$0.76
Op. Cash Flow
$2.2B
Free Cash Flow
$1.72B
Gross Profit
$8.79B
Operating Income
$2.41B
Cash & Equivalents
$1.06B
Total Debt
$750M
Debt / Equity
0.07×
Net Margin
9.7%
Shares Outstanding
1.92B sh
Source: 10-K · filed 2026-02-20 · accession 0001944048-26-000030

Short Interest & Short Volume

2.71 days to cover

FINRA reported short interest of 55,696,920 shares in KVUE as of the October 15, 2026 settlement, a 3.4% decrease from the prior period — about 2.7 days to cover at its recent average daily volume. On October 30, 2026, 22.7% of KVUE volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)55,696,920 shares as of October 15, 2026
Change vs prior period▼ 3.4%
Days to cover2.71 at avg daily volume of 20,572,792
Daily short volume (FINRA facilities)22.7% of 11,751,210 shares on October 30, 2026
4-day average short volume30.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with K →
$19.31
Market cap
$37.09B
Volume
66.6M (3.3× avg)
3-mo avg 20.1M
Last traded · 2026-11-02

show_chartPrice Chart

Loading chart...

feed KVUE - Latest Insights

KVUE
Nov 02, 2026, 9:30 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $19.95
Real-time Price: $19.31 info
Change: -$0.640 (-3%) info
Market Cap: $37.09B info
KVUE
Oct 30, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $19.60
Real-time Price: $19.31 info
Change: -$0.290 (-1%) info
Market Cap: $37.09B info
KVUE
Oct 16, 2026, 5:23 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $18.75
Real-time Price: $19.31 info
Change: +$0.560 (+3%) info
Market Cap: $37.09B info
KVUE
Oct 13, 2026, 12:07 PM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $17.65
Real-time Price: $19.31 info
Change: +$1.66 (+9%) info
Market Cap: $37.09B info
KVUE
Oct 13, 2026, 7:26 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.96
Real-time Price: $19.31 info
Change: +$1.35 (+8%) info
Market Cap: $37.09B info
KVUE
Sep 23, 2026, 6:59 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $17.90
Real-time Price: $19.31 info
Change: +$1.41 (+8%) info
Market Cap: $37.09B info
KVUE
Sep 11, 2026, 12:42 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $17.79
Real-time Price: $19.31 info
Change: +$1.52 (+9%) info
Market Cap: $37.09B info
KVUE
Sep 01, 2026, 10:28 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $18.84
Real-time Price: $19.31 info
Change: +$0.4725 (+3%) info
Market Cap: $37.09B info
KVUE
Aug 06, 2026, 7:01 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $19.30
Real-time Price: $19.31 info
Change: +$0.0099 (+0.05%) info
Market Cap: $37.09B info
KVUE
Aug 06, 2026, 6:55 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $19.15
Real-time Price: $19.31 info
Change: +$0.160 (+0.84%) info
Market Cap: $37.09B info
KVUE
Jul 24, 2026, 2:03 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $19.16
Real-time Price: $19.31 info
Change: +$0.155 (+0.81%) info
Market Cap: $37.09B info
KVUE
Jul 24, 2026, 11:35 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $19.19
Real-time Price: $19.31 info
Change: +$0.125 (+0.65%) info
Market Cap: $37.09B info
KVUE
Jul 13, 2026, 10:34 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $19.27
Real-time Price: $19.31 info
Change: +$0.045 (+0.23%) info
Market Cap: $37.09B info
KVUE
May 07, 2026, 7:50 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $17.70
Real-time Price: $19.31 info
Change: +$1.61 (+9%) info
Market Cap: $37.09B info
KVUE
May 07, 2026, 6:35 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $17.60
Real-time Price: $19.31 info
Change: +$1.71 (+10%) info
Market Cap: $37.09B info
KVUE
May 07, 2026, 6:32 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.60
Real-time Price: $19.31 info
Change: +$1.71 (+10%) info
Market Cap: $37.09B info
KVUE
May 07, 2026, 6:30 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $17.60
Real-time Price: $19.31 info
Change: +$1.71 (+10%) info
Market Cap: $37.09B info
KVUE
Mar 06, 2026, 12:37 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $18.16
Real-time Price: $19.31 info
Change: +$1.15 (+6%) info
Market Cap: $37.09B info
KVUE
Feb 20, 2026, 7:13 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $18.65
Real-time Price: $19.31 info
Change: +$0.660 (+4%) info
Market Cap: $37.09B info
KVUE
Feb 17, 2026, 4:46 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.47
Real-time Price: $19.31 info
Change: +$0.840 (+5%) info
Market Cap: $37.09B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets